GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » KAINOS Laboratories Inc (TSE:4556) » Definitions » Gross Margin %

KAINOS Laboratories (TSE:4556) Gross Margin % : 51.35% (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is KAINOS Laboratories Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. KAINOS Laboratories's Gross Profit for the three months ended in Dec. 2023 was 円669 Mil. KAINOS Laboratories's Revenue for the three months ended in Dec. 2023 was 円1,302 Mil. Therefore, KAINOS Laboratories's Gross Margin % for the quarter that ended in Dec. 2023 was 51.35%.


The historical rank and industry rank for KAINOS Laboratories's Gross Margin % or its related term are showing as below:

TSE:4556' s Gross Margin % Range Over the Past 10 Years
Min: 33.22   Med: 47.48   Max: 54.28
Current: 51.41


During the past 13 years, the highest Gross Margin % of KAINOS Laboratories was 54.28%. The lowest was 33.22%. And the median was 47.48%.

TSE:4556's Gross Margin % is ranked worse than
52.2% of 797 companies
in the Medical Devices & Instruments industry
Industry Median: 52.98 vs TSE:4556: 51.41

KAINOS Laboratories had a gross margin of 51.35% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for KAINOS Laboratories was 2.20% per year.


KAINOS Laboratories Gross Margin % Historical Data

The historical data trend for KAINOS Laboratories's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KAINOS Laboratories Gross Margin % Chart

KAINOS Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.78 51.62 54.28 52.17 51.05

KAINOS Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47.68 49.10 51.75 53.27 51.35

Competitive Comparison of KAINOS Laboratories's Gross Margin %

For the Medical Instruments & Supplies subindustry, KAINOS Laboratories's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


KAINOS Laboratories's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, KAINOS Laboratories's Gross Margin % distribution charts can be found below:

* The bar in red indicates where KAINOS Laboratories's Gross Margin % falls into.



KAINOS Laboratories Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

KAINOS Laboratories's Gross Margin for the fiscal year that ended in Mar. 2023 is calculated as

Gross Margin % (A: Mar. 2023 )=Gross Profit (A: Mar. 2023 ) / Revenue (A: Mar. 2023 )
=2513.5 / 4923.245
=(Revenue - Cost of Goods Sold) / Revenue
=(4923.245 - 2409.754) / 4923.245
=51.05 %

KAINOS Laboratories's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=668.7 / 1302.195
=(Revenue - Cost of Goods Sold) / Revenue
=(1302.195 - 633.5) / 1302.195
=51.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


KAINOS Laboratories  (TSE:4556) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

KAINOS Laboratories had a gross margin of 51.35% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


KAINOS Laboratories Gross Margin % Related Terms

Thank you for viewing the detailed overview of KAINOS Laboratories's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


KAINOS Laboratories (TSE:4556) Business Description

Traded in Other Exchanges
N/A
Address
38-18, Hongo 2-chome, Bunkyo-ku,, Tokyo, JPN
KAINOS Laboratories, Inc. is focused on development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products. It also manufactures, sale and export/import of physicochemical measuring equipment for medical use.

KAINOS Laboratories (TSE:4556) Headlines

No Headlines